Pet Biopharmaceuticals Market - Global Outlook and Forecast 2021-2027

March 2021 | 94 pages | ID: PE2E9B5B4837EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pet Biopharmaceuticals in Global, including the following market information:

Global Pet Biopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Pet Biopharmaceuticals market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pet Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Pet Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%)

• Antiparasitic
• Biological Products
• Antibacterial
• Others

China Pet Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Pet Biopharmaceuticals Market Segment Percentages, By Application, 2020 (%)

• Prevention
• Treatment

Global Pet Biopharmaceuticals Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Pet Biopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Pet Biopharmaceuticals Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Pet Biopharmaceuticals Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Zoetis
• Boehringer Ingelheim
• Merck
• Elanco
• Virbac
• Dechra Veterinary Products
• Ceva
• Vetoquinol
• Ouro Fino Saude
• Norbrook
• Jindun
• Chopperlvya Animal Health
• CAHIC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pet Biopharmaceuticals Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pet Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PET BIOPHARMACEUTICALS OVERALL MARKET SIZE

2.1 Global Pet Biopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Pet Biopharmaceuticals Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pet Biopharmaceuticals Players in Global Market
3.2 Top Global Pet Biopharmaceuticals Companies Ranked by Revenue
3.3 Global Pet Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Pet Biopharmaceuticals Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pet Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pet Biopharmaceuticals Players in Global Market
  3.6.1 List of Global Tier 1 Pet Biopharmaceuticals Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pet Biopharmaceuticals Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pet Biopharmaceuticals Market Size Markets, 2021 & 2027
  4.1.2 Antiparasitic
  4.1.3 Biological Products
  4.1.4 Antibacterial
  4.1.5 Others
4.2 By Type - Global Pet Biopharmaceuticals Revenue & Forecasts
  4.2.1 By Type - Global Pet Biopharmaceuticals Revenue, 2016-2021
  4.2.2 By Type - Global Pet Biopharmaceuticals Revenue, 2022-2027
  4.2.3 By Type - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pet Biopharmaceuticals Market Size, 2021 & 2027
  5.1.2 Prevention
  5.1.3 Treatment
5.2 By Application - Global Pet Biopharmaceuticals Revenue & Forecasts
  5.2.1 By Application - Global Pet Biopharmaceuticals Revenue, 2016-2021
  5.2.2 By Application - Global Pet Biopharmaceuticals Revenue, 2022-2027
  5.2.3 By Application - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Pet Biopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Pet Biopharmaceuticals Revenue & Forecasts
  6.2.1 By Region - Global Pet Biopharmaceuticals Revenue, 2016-2021
  6.2.2 By Region - Global Pet Biopharmaceuticals Revenue, 2022-2027
  6.2.3 By Region - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Pet Biopharmaceuticals Revenue, 2016-2027
  6.3.2 US Pet Biopharmaceuticals Market Size, 2016-2027
  6.3.3 Canada Pet Biopharmaceuticals Market Size, 2016-2027
  6.3.4 Mexico Pet Biopharmaceuticals Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Pet Biopharmaceuticals Revenue, 2016-2027
  6.4.2 Germany Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.3 France Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.4 U.K. Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.5 Italy Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.6 Russia Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.7 Nordic Countries Pet Biopharmaceuticals Market Size, 2016-2027
  6.4.8 Benelux Pet Biopharmaceuticals Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Pet Biopharmaceuticals Revenue, 2016-2027
  6.5.2 China Pet Biopharmaceuticals Market Size, 2016-2027
  6.5.3 Japan Pet Biopharmaceuticals Market Size, 2016-2027
  6.5.4 South Korea Pet Biopharmaceuticals Market Size, 2016-2027
  6.5.5 Southeast Asia Pet Biopharmaceuticals Market Size, 2016-2027
  6.5.6 India Pet Biopharmaceuticals Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Pet Biopharmaceuticals Revenue, 2016-2027
  6.6.2 Brazil Pet Biopharmaceuticals Market Size, 2016-2027
  6.6.3 Argentina Pet Biopharmaceuticals Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pet Biopharmaceuticals Revenue, 2016-2027
  6.7.2 Turkey Pet Biopharmaceuticals Market Size, 2016-2027
  6.7.3 Israel Pet Biopharmaceuticals Market Size, 2016-2027
  6.7.4 Saudi Arabia Pet Biopharmaceuticals Market Size, 2016-2027
  6.7.5 UAE Pet Biopharmaceuticals Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Zoetis
  7.1.1 Zoetis Corporate Summary
  7.1.2 Zoetis Business Overview
  7.1.3 Zoetis Pet Biopharmaceuticals Major Product Offerings
  7.1.4 Zoetis Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.1.5 Zoetis Key News
7.2 Boehringer Ingelheim
  7.2.1 Boehringer Ingelheim Corporate Summary
  7.2.2 Boehringer Ingelheim Business Overview
  7.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Major Product Offerings
  7.2.4 Boehringer Ingelheim Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.2.5 Boehringer Ingelheim Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Pet Biopharmaceuticals Major Product Offerings
  7.3.4 Merck Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.3.5 Merck Key News
7.4 Elanco
  7.4.1 Elanco Corporate Summary
  7.4.2 Elanco Business Overview
  7.4.3 Elanco Pet Biopharmaceuticals Major Product Offerings
  7.4.4 Elanco Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.4.5 Elanco Key News
7.5 Virbac
  7.5.1 Virbac Corporate Summary
  7.5.2 Virbac Business Overview
  7.5.3 Virbac Pet Biopharmaceuticals Major Product Offerings
  7.5.4 Virbac Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.5.5 Virbac Key News
7.6 Dechra Veterinary Products
  7.6.1 Dechra Veterinary Products Corporate Summary
  7.6.2 Dechra Veterinary Products Business Overview
  7.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Major Product Offerings
  7.6.4 Dechra Veterinary Products Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.6.5 Dechra Veterinary Products Key News
7.7 Ceva
  7.7.1 Ceva Corporate Summary
  7.7.2 Ceva Business Overview
  7.7.3 Ceva Pet Biopharmaceuticals Major Product Offerings
  7.4.4 Ceva Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.7.5 Ceva Key News
7.8 Vetoquinol
  7.8.1 Vetoquinol Corporate Summary
  7.8.2 Vetoquinol Business Overview
  7.8.3 Vetoquinol Pet Biopharmaceuticals Major Product Offerings
  7.8.4 Vetoquinol Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.8.5 Vetoquinol Key News
7.9 Ouro Fino Saude
  7.9.1 Ouro Fino Saude Corporate Summary
  7.9.2 Ouro Fino Saude Business Overview
  7.9.3 Ouro Fino Saude Pet Biopharmaceuticals Major Product Offerings
  7.9.4 Ouro Fino Saude Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.9.5 Ouro Fino Saude Key News
7.10 Norbrook
  7.10.1 Norbrook Corporate Summary
  7.10.2 Norbrook Business Overview
  7.10.3 Norbrook Pet Biopharmaceuticals Major Product Offerings
  7.10.4 Norbrook Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.10.5 Norbrook Key News
7.11 Jindun
  7.11.1 Jindun Corporate Summary
  7.11.2 Jindun Business Overview
  7.11.3 Jindun Pet Biopharmaceuticals Major Product Offerings
  7.11.4 Jindun Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.11.5 Jindun Key News
7.12 Chopperlvya Animal Health
  7.12.1 Chopperlvya Animal Health Corporate Summary
  7.12.2 Chopperlvya Animal Health Business Overview
  7.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Major Product Offerings
  7.12.4 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.12.5 Chopperlvya Animal Health Key News
7.13 CAHIC
  7.13.1 CAHIC Corporate Summary
  7.13.2 CAHIC Business Overview
  7.13.3 CAHIC Pet Biopharmaceuticals Major Product Offerings
  7.13.4 CAHIC Pet Biopharmaceuticals Revenue in Global (2016-2021)
  7.13.5 CAHIC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pet Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 2. Pet Biopharmaceuticals Market Drivers in Global Market
Table 3. Pet Biopharmaceuticals Market Restraints in Global Market
Table 4. Key Players of Pet Biopharmaceuticals in Global Market
Table 5. Top Pet Biopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pet Biopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pet Biopharmaceuticals Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pet Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 Pet Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Pet Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pet Biopharmaceuticals Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pet Biopharmaceuticals Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Pet Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pet Biopharmaceuticals Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pet Biopharmaceuticals Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Pet Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pet Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pet Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pet Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pet Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pet Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pet Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pet Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 30. Zoetis Corporate Summary
Table 31. Zoetis Pet Biopharmaceuticals Product Offerings
Table 32. Zoetis Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 33. Boehringer Ingelheim Corporate Summary
Table 34. Boehringer Ingelheim Pet Biopharmaceuticals Product Offerings
Table 35. Boehringer Ingelheim Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 36. Merck Corporate Summary
Table 37. Merck Pet Biopharmaceuticals Product Offerings
Table 38. Merck Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 39. Elanco Corporate Summary
Table 40. Elanco Pet Biopharmaceuticals Product Offerings
Table 41. Elanco Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 42. Virbac Corporate Summary
Table 43. Virbac Pet Biopharmaceuticals Product Offerings
Table 44. Virbac Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 45. Dechra Veterinary Products Corporate Summary
Table 46. Dechra Veterinary Products Pet Biopharmaceuticals Product Offerings
Table 47. Dechra Veterinary Products Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 48. Ceva Corporate Summary
Table 49. Ceva Pet Biopharmaceuticals Product Offerings
Table 50. Ceva Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 51. Vetoquinol Corporate Summary
Table 52. Vetoquinol Pet Biopharmaceuticals Product Offerings
Table 53. Vetoquinol Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 54. Ouro Fino Saude Corporate Summary
Table 55. Ouro Fino Saude Pet Biopharmaceuticals Product Offerings
Table 56. Ouro Fino Saude Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 57. Norbrook Corporate Summary
Table 58. Norbrook Pet Biopharmaceuticals Product Offerings
Table 59. Norbrook Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 60. Jindun Corporate Summary
Table 61. Jindun Pet Biopharmaceuticals Product Offerings
Table 62. Jindun Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 63. Chopperlvya Animal Health Corporate Summary
Table 64. Chopperlvya Animal Health Pet Biopharmaceuticals Product Offerings
Table 65. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)
Table 66. CAHIC Corporate Summary
Table 67. CAHIC Pet Biopharmaceuticals Product Offerings
Table 68. CAHIC Pet Biopharmaceuticals Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Pet Biopharmaceuticals Segment by Type
Figure 2. Pet Biopharmaceuticals Segment by Application
Figure 3. Global Pet Biopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pet Biopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pet Biopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2020
Figure 8. By Type - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 12. US Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 16. Germany Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 17. France Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 24. China Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. India Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 30. Brazil Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pet Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 33. Turkey Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pet Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. Zoetis Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Boehringer Ingelheim Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Elanco Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Virbac Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Dechra Veterinary Products Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Ceva Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Vetoquinol Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Ouro Fino Saude Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Norbrook Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Jindun Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. CAHIC Pet Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)